KR101107312B1 - Cosmetic composition for skin improvement and protection containing peptide - Google Patents
Cosmetic composition for skin improvement and protection containing peptide Download PDFInfo
- Publication number
- KR101107312B1 KR101107312B1 KR1020080138733A KR20080138733A KR101107312B1 KR 101107312 B1 KR101107312 B1 KR 101107312B1 KR 1020080138733 A KR1020080138733 A KR 1020080138733A KR 20080138733 A KR20080138733 A KR 20080138733A KR 101107312 B1 KR101107312 B1 KR 101107312B1
- Authority
- KR
- South Korea
- Prior art keywords
- skin
- cosmetic composition
- moisturizing
- acetylglucosamine
- weight
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 71
- 239000002537 cosmetic Substances 0.000 title claims abstract description 49
- 230000006872 improvement Effects 0.000 title abstract description 28
- 108090000765 processed proteins & peptides Proteins 0.000 title description 5
- 230000003020 moisturizing effect Effects 0.000 claims abstract description 42
- 230000037303 wrinkles Effects 0.000 claims abstract description 39
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 claims abstract description 26
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 claims abstract description 26
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 claims abstract description 26
- 229950006780 n-acetylglucosamine Drugs 0.000 claims abstract description 26
- 239000004472 Lysine Substances 0.000 claims abstract description 19
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims abstract description 19
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000013922 glutamic acid Nutrition 0.000 claims abstract description 14
- 239000004220 glutamic acid Substances 0.000 claims abstract description 14
- 150000003839 salts Chemical class 0.000 claims abstract description 10
- 231100000252 nontoxic Toxicity 0.000 claims abstract description 9
- 230000003000 nontoxic effect Effects 0.000 claims abstract description 9
- 239000004480 active ingredient Substances 0.000 claims abstract description 6
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims description 15
- 239000006071 cream Substances 0.000 claims description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 11
- 239000006210 lotion Substances 0.000 claims description 7
- 239000000839 emulsion Substances 0.000 claims description 6
- COKDJQUOKUWHOK-JWJAOTBVSA-N N[C@@H](CCCCN)C(=O)O.C(CCCCCCCCCCC)(=O)N([C@@H](CCC(=O)O)C(=O)O)C(CCCCCCCCCCC)=O.[Na] Chemical group N[C@@H](CCCCN)C(=O)O.C(CCCCCCCCCCC)(=O)N([C@@H](CCC(=O)O)C(=O)O)C(CCCCCCCCCCC)=O.[Na] COKDJQUOKUWHOK-JWJAOTBVSA-N 0.000 claims description 5
- 239000000654 additive Substances 0.000 claims description 4
- 239000002904 solvent Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 230000000996 additive effect Effects 0.000 claims description 3
- 229930195712 glutamate Natural products 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 3
- 239000000725 suspension Substances 0.000 claims description 3
- 239000006260 foam Substances 0.000 claims description 2
- 239000002304 perfume Substances 0.000 claims description 2
- 239000000049 pigment Substances 0.000 claims description 2
- 239000002453 shampoo Substances 0.000 claims description 2
- 239000003381 stabilizer Substances 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 239000003995 emulsifying agent Substances 0.000 claims 1
- 150000003722 vitamin derivatives Chemical class 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 230000002195 synergetic effect Effects 0.000 abstract description 8
- 206010040880 Skin irritation Diseases 0.000 abstract description 5
- 230000036556 skin irritation Effects 0.000 abstract description 5
- 231100000475 skin irritation Toxicity 0.000 abstract description 5
- 230000009759 skin aging Effects 0.000 abstract description 4
- 230000002265 prevention Effects 0.000 abstract description 2
- 230000036559 skin health Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 52
- 230000000052 comparative effect Effects 0.000 description 49
- 206010040954 Skin wrinkling Diseases 0.000 description 36
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- -1 polyethylene Polymers 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 235000011187 glycerol Nutrition 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- 235000016709 nutrition Nutrition 0.000 description 5
- FCWRAGWRNLDKBB-UQIIZPHYSA-N N[C@@H](CCC(=O)OC(CCCCCCCCCCC)=O)C(=O)OC(CCCCCCCCCCC)=O.[Na] Chemical compound N[C@@H](CCC(=O)OC(CCCCCCCCCCC)=O)C(=O)OC(CCCCCCCCCCC)=O.[Na] FCWRAGWRNLDKBB-UQIIZPHYSA-N 0.000 description 4
- 229920002125 Sokalan® Polymers 0.000 description 4
- 239000003205 fragrance Substances 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 235000013336 milk Nutrition 0.000 description 4
- 239000008267 milk Substances 0.000 description 4
- 210000004080 milk Anatomy 0.000 description 4
- 235000015097 nutrients Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000008213 purified water Substances 0.000 description 4
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 229920001030 Polyethylene Glycol 4000 Polymers 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 241000238557 Decapoda Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- 235000021355 Stearic acid Nutrition 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 235000013871 bee wax Nutrition 0.000 description 2
- 239000012166 beeswax Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000001816 cooling Methods 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- UBHWBODXJBSFLH-UHFFFAOYSA-N hexadecan-1-ol;octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO.CCCCCCCCCCCCCCCCCCO UBHWBODXJBSFLH-UHFFFAOYSA-N 0.000 description 2
- 229920002674 hyaluronan Polymers 0.000 description 2
- 229960003160 hyaluronic acid Drugs 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 231100000021 irritant Toxicity 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 2
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 2
- 229940113124 polysorbate 60 Drugs 0.000 description 2
- 229940032094 squalane Drugs 0.000 description 2
- 239000008117 stearic acid Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 239000012178 vegetable wax Substances 0.000 description 2
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical class CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- JQHAKPORXHHFKD-XRIGFGBMSA-N 2-aminoacetic acid;(2s)-2,6-diaminohexanoic acid Chemical compound NCC(O)=O.NCC(O)=O.NCCCC[C@H](N)C(O)=O JQHAKPORXHHFKD-XRIGFGBMSA-N 0.000 description 1
- HVCOBJNICQPDBP-UHFFFAOYSA-N 3-[3-[3,5-dihydroxy-6-methyl-4-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyoxan-2-yl]oxydecanoyloxy]decanoic acid;hydrate Chemical compound O.OC1C(OC(CC(=O)OC(CCCCCCC)CC(O)=O)CCCCCCC)OC(C)C(O)C1OC1C(O)C(O)C(O)C(C)O1 HVCOBJNICQPDBP-UHFFFAOYSA-N 0.000 description 1
- 238000012935 Averaging Methods 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 229920002101 Chitin Polymers 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- BCYGDJXHAGZNPQ-DCAQKATOSA-N Glu-Lys-Glu Chemical compound OC(=O)CC[C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(O)=O BCYGDJXHAGZNPQ-DCAQKATOSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 229930186217 Glycolipid Natural products 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- SBRWRTIVLPAUFI-RYDKADHRSA-N N[C@@H](CCCCN)C(=O)O.C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)O)C(=O)O Chemical compound N[C@@H](CCCCN)C(=O)O.C(CCCCCCCCCCC)(=O)N[C@@H](CCC(=O)O)C(=O)O SBRWRTIVLPAUFI-RYDKADHRSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 239000004698 Polyethylene Substances 0.000 description 1
- HVUMOYIDDBPOLL-XWVZOOPGSA-N Sorbitan monostearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O HVUMOYIDDBPOLL-XWVZOOPGSA-N 0.000 description 1
- ULUAUXLGCMPNKK-UHFFFAOYSA-N Sulfobutanedioic acid Chemical compound OC(=O)CC(C(O)=O)S(O)(=O)=O ULUAUXLGCMPNKK-UHFFFAOYSA-N 0.000 description 1
- 102000019197 Superoxide Dismutase Human genes 0.000 description 1
- 108010012715 Superoxide dismutase Proteins 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- BWWBBIDHNCOGMM-JWJAOTBVSA-N [Na].NCCCC[C@H](N)C(O)=O.CCCCCCCCCCCC(=O)OC(=O)CC[C@H](N)C(=O)OC(=O)CCCCCCCCCCC Chemical compound [Na].NCCCC[C@H](N)C(O)=O.CCCCCCCCCCCC(=O)OC(=O)CC[C@H](N)C(=O)OC(=O)CCCCCCCCCCC BWWBBIDHNCOGMM-JWJAOTBVSA-N 0.000 description 1
- 230000002745 absorbent Effects 0.000 description 1
- 239000002250 absorbent Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 210000000270 basal cell Anatomy 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- 150000001783 ceramides Chemical class 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 239000007933 dermal patch Substances 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 230000037336 dry skin Effects 0.000 description 1
- 230000002500 effect on skin Effects 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 235000003969 glutathione Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 150000002337 glycosamines Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000013632 homeostatic process Effects 0.000 description 1
- 238000003703 image analysis method Methods 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- SUMDYPCJJOFFON-UHFFFAOYSA-N isethionic acid Chemical compound OCCS(O)(=O)=O SUMDYPCJJOFFON-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 230000037368 penetrate the skin Effects 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920000573 polyethylene Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 229940071089 sarcosinate Drugs 0.000 description 1
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 description 1
- 235000015170 shellfish Nutrition 0.000 description 1
- 230000037067 skin hydration Effects 0.000 description 1
- 230000005808 skin problem Effects 0.000 description 1
- BVMJGZKBXAVKJN-UQKRIMTDSA-M sodium;(4s)-4-amino-5-dodecanoyloxy-5-oxopentanoate Chemical class [Na+].CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC([O-])=O BVMJGZKBXAVKJN-UQKRIMTDSA-M 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 229950011392 sorbitan stearate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 230000003746 surface roughness Effects 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/60—Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/98—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
- A61K8/987—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Zoology (AREA)
- Cosmetics (AREA)
Abstract
본 발명은 디라우로일글루타민산리신 또는 그의 무독성 염, 및 N-아세틸글루코사민을 활성성분으로서 포함하는 피부 보호용 화장료 조성물을 제공한다. The present invention provides a cosmetic composition for skin protection comprising dilauroyl glutamic acid lysine or a non-toxic salt thereof and N-acetylglucosamine as an active ingredient.
본 발명에 따른 피부 보호용 화장료 조성물은 디라우로일글루타민산리신 및 N-아세틸글루코사민의 조합에 의해 피부 보습 및 피부 주름 개선에 있어서 상승적인 효과를 나타내며 피부자극이 거의 없어, 피부를 건강하게 유지하는 효과가 탁월하다. 또한, 상기 화장료 조성물은 보습 효과 및 주름 개선 효과에 의해 피부 노화를 지연시키는 효과가 있어, 피부 보습, 주름 개선, 및 피부 노화 방지용 기능성 화장품으로 이용될 수 있다. The cosmetic composition for skin protection according to the present invention has a synergistic effect in skin moisturizing and skin wrinkle improvement by a combination of dilauroyl glutamic acid lysine and N-acetylglucosamine, and almost no skin irritation, thereby maintaining skin health. Is excellent. In addition, the cosmetic composition has the effect of delaying skin aging by the moisturizing effect and wrinkle improvement effect, it can be used as functional cosmetics for skin moisturizing, wrinkle improvement, and skin aging prevention.
Description
본 발명은 피부 보호용 화장료 조성물에 관한 것으로, 보다 구체적으로는 글리신-리신-글리신 펩타이드 골격을 갖는 양친매성 펩티드와 N-아세틸글루코사민을 포함하여 피부 자극이 없이 안전하면서도 피부 보습 및 주름 개선에 있어 상승작용을 갖는 피부 보호용 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition for protecting the skin, and more particularly, including an amphiphilic peptide having a glycine-lysine-glycine peptide backbone and N-acetylglucosamine, which is safe without skin irritation and synergistic in improving skin moisturization and wrinkles. It relates to a cosmetic composition for protecting the skin.
일반적으로 피부는 외부적 내부적 환경의 각종 요인들에 의해 영향을 받으며, 자외선, 건조한 바람, 열, 습도, 자극적인 세제, 신체적 질병, 생화학적 노화 등에 대해 항상성을 유지하기 위해 변화해 간다. 이러한 변화에 의해 발생되는 피부건조, 색소침착, 주름 등의 피부 트러블의 문제를 해결하기 위해 피부의 보습력을 유지하고 주름을 개선하는 화장품이 사용된다. 피부의 구조는 외측으로부터 각질층, 표피, 진피, 피하조직의 다중구조로 되어 있고, 화장품은 특히 각질층에 대하여 관여하는 중요한 역할을 하고 있다. 각질층에는 수분유지기능으로 아미노산을 주성분으로 하는 천연보습인자(NMF)와 수분증발방지 기능인 세라마이드와 인지질 등의 세포간 지질이 존재한다. In general, the skin is affected by various factors of the external and internal environment and changes to maintain homeostasis against ultraviolet rays, dry winds, heat, humidity, irritant detergents, physical illnesses, biochemical aging, and the like. In order to solve the problems of skin problems such as dry skin, pigmentation, wrinkles caused by such a change, cosmetics are used to maintain the skin's moisturizing power and improve wrinkles. The structure of the skin is composed of multiple structures of the stratum corneum, epidermis, dermis, and subcutaneous tissue from the outside, and cosmetics play an important role in particular involving the stratum corneum. In the stratum corneum, there are intercellular lipids such as natural moisturizing factor (NMF), which contains amino acids as a main ingredient, and ceramides and phospholipids, which function to prevent water evaporation.
레티노이드(Vitamin-A) 및 그 유도체, 아스코르빈산(Vitamin-C) 및 그유도체, 펩타이드류는 콜라겐, 엘라스틴, 히아루론산 등의 생성을 증진시킴으로써; 수퍼옥사이드 디스뮤테이즈류, 카탈라제(Catalase) 등의 효소는 상피세포나 기저세포의 파괴 및 유발경로를 차단함으로써; 그리고 비타민 E, 베타카로틴, 글루타치온, 아스코르빈산 등의 지용성, 수용성 항산화제 등은 각질층의 보습막의 파괴방지 및 신생에 의해, 피부의 보습력를 유지하는 것으로 알려져 있다.Retinoids (Vitamin-A) and its derivatives, ascorbic acid (Vitamin-C) and its derivatives, peptides are produced by enhancing the production of collagen, elastin, hyaluronic acid and the like; Enzymes such as superoxide dismutases and catalases block disruption and induction pathways of epithelial or basal cells; In addition, fat-soluble, water-soluble antioxidants such as vitamin E, beta-carotene, glutathione, and ascorbic acid are known to maintain the skin's moisturizing ability by preventing the breakdown of the moisturizing membrane of the stratum corneum and by the new generation.
N-아세틸글루코사민은 피부 보습 효과가 알려져 있는 물질로서, 게나 새우 등의 갑각류의 외각 중에 포함되는 고분자 다당류 키틴(chitin)을 분해하여 얻을 수 있는 천연형의 아미노당의 일종이다. N-아세틸글루코사민은 우유 중에도 유리상태로 10 m/mL 전후로 포함되어 있고, 뮤코다당이나 당단백질, 당지질의 당쇄 부분의 구성 단위로서 생체 중에 보편적으로 존재하고 있다. 통상 생체 내에서는 글루코오스를 출발물질로 해서 대사에 의해 만들어 내고 있으며, 사람에 있어서 안전성이 높은 생체 성분 중의 하나이다. N-아세틸글루코사민은 히알루론산과 같은 뮤코다당의 생합성을 촉진하여 피부 수화 기능을 향상시키는 효과가 탁월하여, 보습제 및 주름 개선 제로서의 사용이 제안되어 왔다(한국특허공개 2005-0078283, 2006-0123609).N-acetylglucosamine is a substance known for its skin moisturizing effect, and is a kind of natural amino sugar that can be obtained by decomposing high polysaccharide chitin contained in the shell of shellfish such as crabs and shrimps. N-acetylglucosamine is freely contained in milk at around 10 m / mL and is commonly present in vivo as a structural unit of the sugar chain portion of mucopolysaccharide, glycoprotein, and glycolipid. Normally, in vivo, glucose is used as a starting material, and is produced by metabolism, and is one of high safety biological components in humans. N-acetylglucosamine promotes the biosynthesis of mucopolysaccharides such as hyaluronic acid to enhance skin hydration, and has been proposed for use as a moisturizer and an antiwrinkle agent (Korean Patent Publication 2005-0078283, 2006-0123609) .
또한, 디라우로일글루타민산리신은 1쇄 1친수기인 라우로일글루타민산나트륨염 2 개가 리신을 스페이스로 하여 연결되어 있는 펩티드 골격(Glu-Lys-Glu)을 가지며, 제미니형 양친매성을 나타낸다.(ROSEN M, Geminis J.,A NEW Generation of Surfactants, CHEMTECH,23,30(1993)). 디라우로일글루타민산리신은 손상된 피부을 회복시키는 효과 및 피부 보습 효과를 가지며, 피부자극물질과 병용 시 피부 자극을 완화하는 효과가 있는 것으로 알려져 있다(田村幸永, 山脇幸男, 香粧 洗淨材技報, 2. 25(2007)). In addition, dilauroyl glutamate lysine has a peptide backbone (Glu-Lys-Glu) in which two lauroyl glutamate sodium salts, each of which is a single-chain, one hydrophilic group, are linked with lysine as a space, and show a gemini-like amphipathicity. ROSEN M, Geminis J., A NEW Generation of Surfactants, CHEMTECH, 23, 30 (1993). Dilauroylglutamic acid lysine is known to have the effect of restoring damaged skin and moisturizing skin, and to reduce skin irritation when used in combination with skin irritants (田村 幸 永, 山 脇 幸 男, 香 粧 粧 技2., 2. 25 (2007).
앞서 살펴본 바와 같이, 다양한 물질들이 피부의 보습 및 주름 개선등을 포함한 피부의 보호를 위해 사용될 수 있다. 그러나, 피부 침투가 용이하지 않은 화장료 조성물로서의 한계로 인해 상기 물질들을 피부에 적용함으로써 탁월한 피부의 보습 및 주름 개선 효과를 보기는 쉽지 않다. 따라서, 보다 향상된 피보 보호 효과를 갖는 화장료 조성물의 개발이 끊임없이 요구되고 있다.As discussed above, various materials may be used for protecting the skin, including moisturizing the skin and improving wrinkles. However, due to the limitation as a cosmetic composition that is not easy to penetrate the skin, it is not easy to see the excellent skin moisturizing and wrinkle improvement effect by applying the substances to the skin. Therefore, there is a constant demand for the development of a cosmetic composition having an improved pivo protection effect.
이에 본 발명자들은 피부 보습 및 주름 개선을 포함한 피부 보호에 있어서 보다 우수한 효과를 갖는 화장료 조성물을 개발하기 위해 연구한 결과, 종래에 피부 보습 및 주름 개선 효과가 있는 것으로 공지되어 있는 물질을 조합함으로써 상기 피부 보호 효과의 측면에 있어서 현저한 효과를 나타낸다는 것을 발견하여 본 발명을 완성하게 되었다. Accordingly, the present inventors studied to develop a cosmetic composition having a better effect on skin protection, including skin moisturizing and wrinkle improvement, and as a result, by combining a substance known to have a skin moisturizing and wrinkle improving effect, The present invention has been completed by finding a significant effect in terms of protective effect.
따라서, 본 발명의 목적은 피부 보습 및 주름 개선를 포함한 피부 보호용 화장료 조성물을 제공하는 것이다. Accordingly, it is an object of the present invention to provide a cosmetic composition for skin protection including skin moisturizing and wrinkle improvement.
본 발명의 다른 목적은 상기 화장료 조성물을 피부에 도포하여 피부 보습 또는 피부 주름을 개선시키는 방법을 제공하는 것이다. Another object of the present invention is to provide a method of applying the cosmetic composition to the skin to improve skin moisturizing or skin wrinkles.
상기 목적을 달성하기 위해서, 본 발명은 디라우로일글루타민산리신 또는 그의 무독성 염, 및 N-아세틸글루코사민을 활성성분으로서 포함하는 피부 보호용 화장료 조성물을 제공한다. In order to achieve the above object, the present invention provides a cosmetic composition for skin protection comprising dilauroyl glutamic acid lysine or a non-toxic salt thereof and N-acetylglucosamine as an active ingredient.
또한, 본 발명은 상기 본 발명에 따른 화장료 조성물을 피부에 도포하는 것을 포함하는 피부 보습 또는 피부 주름을 개선시키는 방법을 제공한다. The present invention also provides a method for improving skin moisturizing or skin wrinkles comprising applying the cosmetic composition according to the present invention to the skin.
이하, 본 발명을 보다 상세하게 설명한다. Hereinafter, the present invention will be described in more detail.
본 발명에 따른 화장료 조성물은 종래 보습 효과 및 주름 개선 등의 피부보호 효과가 공지되어 있던 디라우로일글루타민산리신 또는 그의 무독성 염, 및 N-아 세틸글루코사민을 최초로 조합한 화장료 조성물로서, 이러한 조합에 의해 각각의 성분은 그 자체가 가지고 있던 피부 보호 효과가 상승적으로 증가하여, 매우 우수한 피부보호 효과를 나타낸다. The cosmetic composition according to the present invention is a cosmetic composition for the first combination of dilauroyl glutamic acid lysine or a nontoxic salt thereof, and N-acetylglucosamine, which have been known in the prior art for protecting skin such as moisturizing effect and wrinkle improvement. As a result, each component synergistically increases the skin protection effect itself has, and shows a very good skin protection effect.
본 발명에 따른 화장료 조성물의 용도인 "피부 보호"는 피부의 전반적인 건강 상태를 향상시키기 위한 것으로서, 구체적으로 "보습 개선", "주름 개선", 또는 "상기 용도의 조합"등을 포함지만 이에 한정되는 것은 아니다. 따라서, 본 발명의 바람직한 구현예에 따르면, 본 발명은 (a) 디라우로일글루타민산리신 또는 그의 무독성 염, 및 N-아세틸글루코사민을 활성성분으로서 포함하는 피부 보습 개선용 화장료 조성물, (b) 디라우로일글루타민산리신 또는 그의 무독성 염, 및 N-아세틸글루코사민을 활성성분으로서 포함하는 피부 주름 개선용 화장료 조성물, (c) 디라우로일글루타민산리신 또는 그의 무독성 염, 및 N-아세틸글루코사민을 활성성분으로서 포함하는 피부 보습 및 주름 개선용 화장료 조성물을 제공한다."Skin protection" as a use of the cosmetic composition according to the present invention is intended to improve the overall health of the skin, and specifically includes, but is not limited to, "moisturizing", "wrinkle improvement", or "combination of the above", etc. It doesn't happen. Therefore, according to a preferred embodiment of the present invention, the present invention provides a cosmetic composition for improving skin moisturization comprising (a) dilauroyl glutamic acid lysine or a non-toxic salt thereof and N-acetylglucosamine as an active ingredient, (b) di Cosmetic composition for improving skin wrinkles comprising lauroyl glutamic acid lysine or non-toxic salt thereof and N-acetylglucosamine as active ingredient, (c) dilauroyl glutamic acid lysine or non-toxic salt thereof and N-acetylglucosamine as active ingredient It provides a cosmetic composition for skin moisturizing and wrinkle improvement comprising as.
상기 디라우로일글루타민산리신의 무독성염은 디라우로일글루타민산 리신의 효과를 저해하거나 독성을 나타내는 것이 아니라면 임의의 염 형태가 이용될 수 있으며, 특히 소듐 디라우로일글루타민산리신이 바람직하다.The non-toxic salt of dilauroyl glutamic acid lysine may be used in any salt form as long as it does not inhibit or exhibit the toxicity of dilauroyl glutamic acid lysine, and sodium dilauroyl glutamate is particularly preferred.
본 발명의 조성물은 바람직하게는 디라우로일글루타민산리신 100 중량부에 대해 N-아세틸글루코사민 5 내지 30 중량부, 더욱 바람직하게는 10-20 중량부를 포함할 수 있으나, 이에 한정되는 것은 아니다. 본 발명의 조성물은 바람직하게는 디라우로일글루타민산리신 0.01 내지 10.0 중량% 및 N-아세틸글루코사민 0.001 내지 5.0 중량%를 포함할 수 있으며, 상기 범위보다 부족할 경우에는 피부 보습력 및 주름 개선 증진 효과가 미약할 수 있으며, 상기 범위를 넘어설 경우는 화장료 조성물이 표면의 거칠감, 뭉글거림이 심하여 안정성의 측면에서 적절하지 않다. The composition of the present invention may preferably include 5 to 30 parts by weight of N-acetylglucosamine, more preferably 10 to 20 parts by weight based on 100 parts by weight of dilauroyl glutamic acid lysine, but is not limited thereto. The composition of the present invention may preferably comprise 0.01 to 10.0% by weight of lysine dilauroyl glutamate and 0.001 to 5.0% by weight of N-acetylglucosamine, and when it is less than the above range, the skin moisturizing and wrinkle improvement enhancing effect is weak. If it exceeds the above range, the cosmetic composition is not appropriate in terms of stability because the surface roughness, lumping is severe.
상기 본 발명의 조성물은 당해 화장품 분야에 널리 공지되어 있는 방법으로 특정 제형으로 제조될 수 있으며, 화장품학적으로 허용되는 첨가제를 추가적으로 더 포함할 수 있다. 이러한 첨가제로는 안정화제, 용해화제, 유탁화제, 비타민, 안료, 향료, 또는 이들이 조합 등이 있으나, 이에 한정되는 것은 아니며, 제조하고자 제형의 종류에 따라 달라질 수 있다.The composition of the present invention may be prepared in a specific formulation by a method well known in the cosmetic field, and may further include a cosmetically acceptable additive. Such additives include, but are not limited to, stabilizers, solubilizers, emulsions, vitamins, pigments, fragrances, or combinations thereof, and may vary depending on the type of formulation to be prepared.
본 발명의 피부 보호용 화장료 조성물은 당해 기술분야에서 통상적으로 제조되는 임의의 제형으로 제조될 수 있으며, 예를 들어 용액, 현탁액, 유탁액, 페이스트, 겔, 크림, 로션, 샴푸, 계면활성제-함유 클렌징, 리퀴드 파운데이션 및 크림 파운데이션 등으로 제형화 될 수 있으나, 이에 한정되는 것은 아니다. 보다 구체적으로는, 유연 화장수, 영양 화장수, 영양 유액, 영양 크림, 마사지 크림, 에센스, 아이크림, 클렌징 크림, 클렌징 폼, 클렌징 워터, 팩, 헤어 에센스, 린스 등의 제형으로 제조될 수 있다.The cosmetic composition for protecting the skin of the present invention may be prepared in any formulation commonly prepared in the art, for example, solutions, suspensions, emulsions, pastes, gels, creams, lotions, shampoos, surfactant-containing cleansing It may be formulated as a liquid foundation and a cream foundation, but is not limited thereto. More specifically, it may be prepared in a formulation such as softening lotion, nourishing lotion, nutrient latex, nourishing cream, massage cream, essence, eye cream, cleansing cream, cleansing foam, cleansing water, pack, hair essence, rinse.
본 발명의 제형이 용액 또는 유탁액인 경우에는 담체 성분으로서 용매, 용해화제, 또는 유탁화제가 이용되고, 예컨대 물, 에탄올, 카르복실비닐폴리머, 프로필렌글리콜, 1,3-부틸렌글리콜, 글리세린 지방족 에스테르, 폴리에틸렌경화피마자유, 방부제 또는 소르비탄 지방산 에스테르가 있다. When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer, or emulsion agent is used as a carrier component, for example, water, ethanol, carboxyvinyl polymer, propylene glycol, 1,3-butylene glycol, glycerin aliphatic Esters, polyethylene hardened castor oil, preservatives or sorbitan fatty acid esters.
본 발명의 제형이 현탁액인 경우에는 담체 성분으로서 물, 향료, 농글리세린, 부틸렌글리콜 또는 프로필렌글리콜과 같은 액상의 희석제, 에톡실화이소스테라 일 알코올, 폴리옥시에틸렌 소르비톨 에스테르, 또는 폴리옥시에틸렌 소르비탄 에스테르와 같은 유화현탁제, 미세결정성 셀룰로오스, 카르복시비닐폴리머, 점증제 또는 방부제 등이 이용될 수 있다. When the dosage form of the present invention is a suspension, a liquid diluent such as water, fragrance, concentrated glycerin, butylene glycol or propylene glycol, ethoxylated iso terra teryl alcohol, polyoxyethylene sorbitol ester, or polyoxyethylene sorbitan as a carrier component Emulsifying suspending agents such as esters, microcrystalline cellulose, carboxyvinyl polymers, thickeners or preservatives and the like can be used.
본 발명의 제형이 계면활성제 함유 클렌징이 경우에는 담체 성분으로서 지방족 알코올 설페이트, 지방족 알코올 에테르 설페이트, 설포숙신산 모노에스테르, 이세티오네이트, 이미다졸리늄 유도체, 메틸타우레이트, 사르코시네이트, 지방산 아미드 에테르 설페이트, 알킬아미도베타인, 지방족 알코올, 지방산 글리세리드, 지방산 디에탄올아미드, 식물성유, 라놀린 유도체, 또는 에톡실화 글리세롤 지방산 에스테르 등이 이용될 수 있다. In the case where the formulation of the present invention is a surfactant-containing cleansing, as a carrier component, an aliphatic alcohol sulfate, an aliphatic alcohol ether sulfate, a sulfosuccinic acid monoester, isethionate, an imidazolinium derivative, a methyltaurate, a sarcosinate, a fatty acid amide ether Sulfates, alkylamidobetaines, aliphatic alcohols, fatty acid glycerides, fatty acid diethanolamides, vegetable oils, lanolin derivatives, ethoxylated glycerol fatty acid esters, and the like.
본 발명에 따른 화장료 조성물은 하기 실시예에서 실험에 의해 확인한 바와 같이, 디라우로일글루타민산리신 및 N-아세틸글루코사민의 조합에 의해 피부 보습 및 피부 주름 개선에 있어서 상승적인 효과를 나타낸다. 뿐만 아니라, 본 발명에 따른 화장료 조성물은 피부 자극이 극히 적어 화장품으로서 안전하게 사용할 수 있다.The cosmetic composition according to the present invention exhibits a synergistic effect on skin moisturization and skin wrinkle improvement by the combination of dilauroyl glutamic acid lysine and N-acetylglucosamine, as confirmed by experiments in the following examples. In addition, the cosmetic composition according to the present invention can be used safely as a cosmetic since the skin irritation is extremely low.
따라서, 본 발명은 다른 측면에 있어서, 상기 본 발명에 따른 화장료 조성물을 피부에 도포하여 피부 보습 또는 피부 주름을 개선시키는 방법을 제공한다.Therefore, in another aspect, the present invention provides a method of applying the cosmetic composition according to the present invention to the skin to improve skin moisturizing or skin wrinkles.
본 발명의 화장료 조성물은 적용하고자 하는 피부 면적에 따라 적절한 양을 피부에 도포함으로써 적용될 수 있으며, 필요에 따라 하루 1 회 내지 수 회 반복하여 사용할 수 있다. 적용하는 양 및 횟수는 개인의 피부 상태, 연령 등에 따라 필요에 의해 증감할 수 있다.The cosmetic composition of the present invention may be applied by applying an appropriate amount to the skin according to the skin area to be applied, and may be used once to several times a day as needed. The amount and frequency of application can be increased or decreased as necessary according to the skin condition, age, etc. of the individual.
앞서 살펴본 바와 같이, 본 발명에 따른 피부 보호 화장료 조성물은 디라우로일글루타민산리신 및 N-아세틸글루코사민의 조합에 의해 피부 보습 및 피부 주름 개선에 있어서 상승적인 효과를 나타내며 피부자극이 거의 없어, 피부를 건강하게 유지하는 효과가 탁월하다. 또한, 상기 화장료 조성물은 보습 효과 및 주름 개선 효과에 의해 피부 노화를 지연시키는 효과가 있어, 피부 보습, 주름 개선, 및 피부 노화 방지용 기능성 화장품으로 이용될 수 있다. As described above, the skin care cosmetic composition according to the present invention exhibits a synergistic effect in skin moisturizing and skin wrinkle improvement by a combination of dilauroyl glutamic acid lysine and N-acetylglucosamine and almost no skin irritation. Excellent effect to keep healthy. In addition, the cosmetic composition has the effect of delaying skin aging by the moisturizing effect and wrinkle improvement effect, it can be used as functional cosmetics for skin moisturizing, wrinkle improvement, and skin aging prevention.
이하, 본 발명을 실시예를 통하여 더욱 상세히 설명한다. 그러나, 이들 실시예는 본 발명을 예시적으로 설명하기 위한 것으로, 본 발명의 범위가 이들 실시예에 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail with reference to examples. However, these examples are for illustrative purposes only, and the scope of the present invention is not limited to these examples.
실시예 1: 화장수 제조Example 1: Make-up
하기 표 1에 나타낸 바와 같이, 카르복시비닐폴리머 0.1 중량%, 부틸렌글리콜 3.0 중량%, 글리세린 1.0 중량%, 소듐 디라우로일글루타민산리신 0.1 중량%, N-아세틸글루코사민 0.01 중량%, PEG 4000 0.5 중량%를 정제수에 가열, 혼합 용해하여 수성 혼합물을 제조하였다. 그런 다음, 폴리옥시에틸렌 경화피마자유 0.2 중량%, 폴리소르베이트 80 0.2중량%, 트리에탄올아민 0.1 중량%, 메틸파라벤 적량, 및 향료적량을 에탄올 6.0 중량%에 용해한 것을 상기 수성 혼합물과 혼합하여 화장수를 제조하였다.As shown in Table 1, 0.1% by weight of carboxyvinyl polymer, 3.0% by weight of butylene glycol, 1.0% by weight of glycerin, 0.1% by weight of sodium dilauroyl glutamate, 0.01% by weight of N-acetylglucosamine, 0.5% by weight of PEG 4000 The mixture was heated, mixed and dissolved in purified water to prepare an aqueous mixture. Then, 0.2% by weight of polyoxyethylene cured castor oil, 0.2% by weight of polysorbate 80, 0.1% by weight of triethanolamine, methylparaben amount, and perfume amount in 6.0% by weight of ethanol were mixed with the aqueous mixture to make up the lotion. Prepared.
비교예 1,2, 및 3: 화장수 제조Comparative Examples 1, 2, and 3: make up lotion
상기 실시예 1에서 상기 표 1에 나타낸 조성비로 사용한 것을 제외하고는 상기 실시예 1과 동일한 방법으로 실시하여, 비교예 1, 2, 및 3의 화장수를 제조하였다. Except for using the composition ratio shown in Table 1 in Example 1 was carried out in the same manner as in Example 1, to prepare a lotion of Comparative Examples 1, 2, and 3.
실시예 2: 영양유액 제조Example 2: Nutritional Milk Preparation
하기 표 2에 나타낸 바와 같이, 베지터블왁스 0.5중량%, 세탄올 0.5중량%, 세토스테아릴알코올 0.8 중량%, 스테아린산 0.6중량%, 자기유화형 모노스테아린산 0.6 중량%, 친유형 모노스테아린산 0.5 중량%, 밀납 0.50 중량%, 파라핀왁스 0.5 중량%, 스쿠알란 3.0 중량%, 폴리솔베이트 60 1.2 중량%, 세스퀴올레인산 0.8 중량%, 향료을 따로 혼합하여 가열 용해하여 알코올 혼합물을 제조하였다. As shown in Table 2, 0.5 wt% vegetable wax, 0.5 wt% cetanol, 0.8 wt% cetostearyl alcohol, 0.6 wt% stearic acid, 0.6 wt% self-emulsifying monostearic acid, 0.5 wt% lipophilic monostearic acid, 0.50% by weight of beeswax, 0.5% by weight of paraffin wax, 3.0% by weight of squalane, 1.2% by weight of polysorbate 60, 0.8% by weight of sesquioleic acid, and fragrance were separately mixed to heat and dissolved to prepare an alcohol mixture.
그런 다음, N-아세틸글루코사민 0.1 중량%, 소듐 디라우로일글루타민산리신 1.0 중량%, PEG 4000 0.5 중량%, 농글리세린 4.00 중량%, 부틸렌글리콜 6.00 중량%, 카르복시폴리머 0.08 중량%, 트리에탄올아민 0.08 중량%, 적량의 방부제, 및 나머지 잔량의 정제수를 혼합하여 가열 용해한 것에 상기 알코올 혼합물을 넣어 교반 냉각시켜 영양유액을 제조하였다.Then, 0.1% by weight of N-acetylglucosamine, 1.0% by weight of sodium dilauroylglutamic acid lysine, 0.5% by weight of PEG 4000, 4.00% by weight of concentrated glycerin, 6.00% by weight of butylene glycol, 0.08% by weight of carboxypolymer, 0.08% of triethanolamine The nutrient emulsion was prepared by stirring and cooling the alcohol mixture by mixing the weight%, an appropriate amount of preservative, and the remaining amount of purified water with heat to dissolve it.
비교예 4, 5, 및 6: 영양유액 제조Comparative Examples 4, 5, and 6: Preparation of Nutrient Milk
상기 실시예 2에서 상기 표 2에 나타낸 조성비로 사용한 것을 제외하고는 상 기 실시예 2와 동일한 방법으로 실시하여 비교예 4, 5, 및 6의 영양유액을 각각 제조하였다.Except for using the composition ratio shown in Table 2 in Example 2 was carried out in the same manner as in Example 2 to prepare the nutrient milk of Comparative Examples 4, 5, and 6.
실시예 3: 영양크림 제조Example 3: Nutrition Cream
하기 표 3에 나타낸 바와 같이, 베지터블왁스 1.0 중량%, 세탄올 0.9 중량%, 세토스테아릴알코올 1.00 중량%, 스테아린산 0.8 중량%, 자기유화형 모노스테아린산 1.0 중량%, 친유형 모노스테아린산 1.00 중량%, 밀납 1.50 중량%, 스쿠알란 6.00 중량%, 파라핀왁스 0.5 중량%, 카프릭 카프릴릭트리글리세라이드 3.00 중량%, 디메치콘 0.50 중량%, 폴리솔베이트 60 1.20 중량%, 소르비탄스테아레이트 0.8 중량%, 및 향료를 따로 혼합, 가열 용해하여 알코올 혼합물을 제조하였다. As shown in Table 3 below, 1.0 wt% vegetable wax, 0.9 wt% cetanol, 1.00 wt% cetostearyl alcohol, 0.8 wt% stearic acid, 1.0 wt% self-emulsifying monostearic acid, 1.00 wt% lipophilic monostearic acid, Beeswax 1.50 wt%, squalane 6.00 wt%, paraffin wax 0.5 wt%, capric caprylic triglyceride 3.00 wt%, dimethicone 0.50 wt%, polysorbate 60 1.20 wt%, sorbitan stearate 0.8 wt%, and The fragrance was separately mixed and heated to prepare an alcohol mixture.
그런 다음, N-아세틸글루코사민 1.0 중량%, PEG 4000 0.5 중량%, 소듐 디라우로일글루타민산리신 5.0 중량%, 농글리세린 6.00 중량%, 부틸렌글리콜 6.00 중량%, 카르복시비닐폴리머 0.1 중량%, 트리에탄올아민 0.10 중량%, 및 적량의 방부제를 잔량의 정제수와 혼합하여 가열 용해한 것에 상기 알코올 혼합물을 넣어 교반 냉각시켜 영양크림을 제조하였다.Then, 1.0% by weight of N-acetylglucosamine, 0.5% by weight of PEG 4000, 5.0% by weight of sodium dilauroyl glutamate, 6.00% by weight of concentrated glycerin, 6.00% by weight of butylene glycol, 0.1% by weight of carboxyvinyl polymer, triethanolamine The nutritional cream was prepared by stirring and cooling the said alcohol mixture in 0.10 weight% and the appropriate amount of preservatives by mixing with a residual amount of purified water and heating it.
비교예 7, 8, 및 9: 영양크림 제조Comparative Examples 7, 8, and 9: Nutritional Cream Preparation
상기 실시예 3에서 상기 표 3에 나타낸 조성비로 사용한 것을 제외하고는 동일한 방법으로 실시하여 상기 비교예 7, 8, 및 9의 영양크림을 제조하였다. The nutrition cream of Comparative Examples 7, 8, and 9 was prepared in the same manner as in Example 3, except that the composition ratios shown in Table 3 were used.
실험예 1: 코네오메터 CM 825 를 이용한 보습력 측정Experimental Example 1 Measurement of Moisturizing Force Using Coneometer CM 825
상기 실시예 및 비교예 조성물에 대하여 보습 효과를 코네오메터 CM 825(Corneometer CM 825, Courage+Khazaka 사)를 사용하여 보습력을 측정하였다. 각각의 시료 당 35-60대 여성 5명을 대상으로 상박부 2 x 2 ㎠ , 8 구획 나누어 구 분하고, 물로 여러 차례 세정한 후 자극 없이 수분을 제거하였다. 15 분경과 후, 시료를 각각 2 구획에 대하여 10 ㎕ 씩 점적하여 고르게 도포하였다. 2 시간 경과 후, 코네오메터를 이용하여 하나의 구획 당 5 회 측정하였다. 실험은 실내온도는 21± 2℃, 상대습도 50± 5%의 항온 항습실에서 실시하였다. 측정값은 5회 측정하여 얻어진 값을 평균하여 사용하였으며, 대상자 5 명의 평균값을 이용하여 표 4에 나타내었다. 하기 표 4에서는 비교예 1에 대해 실시예1, 비교예 2, 3의 보습력 증가를 비교하기 위해 비교예 1에 대한 실시예1, 비교예 2, 3의 보습력 증가를 함께 나타내었다. 또한, 실시예 2 및 비교예 4-6, 실시예 3 및 비교예 7-9에 대해서도 동일한 방식으로 나타내었다. The moisturizing effect was measured using the Coneometer CM 825 (Corneometer CM 825, Courage + Khazaka) for the Examples and Comparative Example compositions. Five women in their 35's and 60's for each sample were divided into 8 sections of the upper arm 2 x 2 cm 2, and washed several times with water, and then water was removed without stimulation. After 15 minutes, the samples were applied evenly by dropping 10 µl into each of the two sections. After 2 hours, measurements were made 5 times per compartment using a coneometer. The experiment was conducted in a constant temperature and humidity room with a room temperature of 21 ± 2 ℃ and a relative humidity of 50 ± 5%. The measured values were used by averaging the values obtained by measuring five times, and are shown in Table 4 using the average value of five subjects. Table 4 shows the increase in the moisturizing power of Example 1, Comparative Examples 2, 3 for Comparative Example 1 to compare the increase in the moisturizing power of Example 1, Comparative Examples 2, 3 with respect to Comparative Example 1. In addition, Example 2, Comparative Examples 4-6, Example 3, and Comparative Example 7-9 are also shown in the same manner.
상기 결과에서 실시예 1~3에서는 소듐 디라우로일글루타민산리신, N-아세틸글루코사민의 두 가지 모두의 사용에 의한 증감을, 비교예 2,3,5,6,8,9에서는 각각 따로 사용할 경우의 보습력 증감을 나타낸다. 실시예의 1, 2, 3의 각각의 보습력 증가가 비교예 2,3의 보습력 증가의 합, 비교예 5,6의 보습력 증가의 합, 비교예 8,9의 보습력 증가의 합보다 각각 우수한 결과가 도출 되었다. 따라서, 보습력 증가의 측면에 있어서 본원발명의 실시예 1-3의 제제가 소듐 디라우로일글루타민산리 신 또는 N-아세틸글루코사민을 각각 사용할 경우에 비해 상승적인 효과를 갖는다고 할 수 있다. In Examples 1 to 3, the increase and decrease by the use of both sodium dilauroyl glutamic acid lysine and N-acetylglucosamine were used in Comparative Examples 2, 3, 5, 6, 8, and 9, respectively. It shows the increase and decrease of moisturizing ability. The increase in the moisturizing power of each of Examples 1, 2 and 3 is superior to the sum of the increase in the moisturizing power of Comparative Examples 2 and 3, the sum of the increase in the moisturizing power of Comparative Examples 5 and 6, and the increase in the moisturizing power of Comparative Examples 8 and 9, respectively. Was derived. Therefore, in terms of increasing the moisturizing power, it can be said that the formulations of Examples 1-3 of the present invention have a synergistic effect compared with the case of using sodium dilauroyl glutamic acid lysine or N-acetylglucosamine, respectively.
실험예 2: 데시케이터를 이용한 보습력 측정Experimental Example 2: Measurement of moisturizing power using a desiccator
상기 실시예 및 비교예에 대하여 보습 효과를 아래와 같이 액상에서의 수분 증발 억제율 차이를 이용하여 보습력을 측정하였으며, 각각 실시예 또는 비교예 제제의 30%를 정제수에 용해하여 사용하였다. For the Examples and Comparative Examples, the moisturizing effect was measured using the difference in the rate of moisture evaporation in the liquid phase as follows, and 30% of the Examples or Comparative Example formulations were dissolved in purified water, respectively.
시료 10 g를 표면적이 일정한 컵에 적정한 후, 완전 건조된 염화칼슘(CaCl2)을 흡습제로 사용하여 온도 35℃로 조절한 데시게이터에서 24 시간 동안 방치하였고, 24 시간 후 각 시료의 무게를 5 회 측정한 평균값을 이용하여 보습력을 측정하였다. 그 결과를 표 5에 나타내었다.After 10 g of the sample was titrated into a cup with a constant surface area, it was left for 24 hours in a desiccator adjusted to a temperature of 35 ° C. using completely dried calcium chloride (CaCl 2 ) as an absorbent, and each sample was weighed 5 times after 24 hours. Moisturizing power was measured using the measured average value. The results are shown in Table 5.
상기 실험결과에 따르면, 실시예 1의 보습력 증가율은 비교예 2, 3의 증가율의 합보다 크고, 실시예 2의 보습력 증가율은 비교예 5, 6의 증가율의 합보다 크고, 실시예 3의 보습력 증가율은 비교예 8, 9의 증가율의 합보다 큰 것으로 나타났다. 따라서, 소듐 디라우로일글루타민산리신 및 N-아세틸글루코사민의 두 가지 모두를 사용한 실시예 1, 2, 및 3의 제제는 각각 단독으로 사용할 경우의 비교예에 비해 보습효과에 있어서 상승적인 효과를 갖는 것으로 나타내었다. According to the experimental results, the moisturizing power increase rate of Example 1 is greater than the sum of the increase rates of Comparative Examples 2, 3, the moisturizing power increase rate of Example 2 is greater than the sum of the increase rates of Comparative Examples 5, 6, the moisturizing power increase rate of Example 3 Was greater than the sum of the increase rates of Comparative Examples 8 and 9. Therefore, the formulations of Examples 1, 2, and 3 using both sodium dilauroyl glutamate and N-acetylglucosamine each have a synergistic effect on the moisturizing effect compared to the comparative examples when used alone. It is shown.
실험예 3. 주름개선효과Experimental Example 3. Wrinkle improvement effect
상기 실시예 1, 2, 3 및 비교예 1-9에서 제조한 조성물을 사용하여 주름개선 효과를 측정하였다.Wrinkle improvement effect was measured using the composition prepared in Examples 1, 2, 3 and Comparative Examples 1-9.
35~60 세의 여성 50 명을 대상으로 1 일 2 회씩 상기 실시예 1,2,3 및 비교예 1-9에서 각각 제조한 화장료 조성물을 눈 주위에 균일하게 도포하도록 하였고, 측정부위는 눈가 주름(crow's feet)으로 정하여 총 3개월 동안 실시하였다.50 women 35 to 60 years old were applied twice daily to the cosmetic compositions prepared in Examples 1, 2 and 3 and Comparative Examples 1-9 uniformly around the eyes, and the measurement area was wrinkled around the eyes. (crow's feet) was conducted for a total of three months.
피험자의 왼쪽 눈가에는 상기 실시예 1,2,3에서 제조한 화장료 조성물을 적용하였고, 오른쪽 눈가에는 상기 비교예 1-9에서 제조한 화장료 조성물을 적용하였다. 3 개월 후 주름의 완화 정도는 육안판정(대조군과 비교하여 개선 없음, 약간의 개선, 중등도의 개선, 상당한 개선의 4 단계로 판정)하여 하기 표 6에 나타내었고, 화장료 조성물의 적용 전과 적용 후의 눈가 주름 주형(replica)을 영상분석법으로 주름의 깊이(㎛)를 측정하여 rm 결과를 하기 표 7에 나타내었다.The cosmetic composition prepared in Examples 1, 2 and 3 was applied to the left eye of the test subject, and the cosmetic composition prepared in Comparative Examples 1-9 was applied to the right eye. After 3 months, the degree of wrinkle relief was visually determined (judged by four stages of no improvement, slight improvement, moderate improvement, and significant improvement as compared with the control group) and is shown in Table 6 below, and before and after application of the cosmetic composition. Wrinkle template (replica) by measuring the depth of wrinkles (㎛) by image analysis method rm results are shown in Table 7 below.
상기 표 6에 따르면, 주름의 개선율이 실시예 1의 비교예 1에 대한 개선율 증가가 비교예 2, 3의 비교예 1에 대한 개선율 증가의 합보다 크고, 실시예 2의 비 교예 4에 대한 개선율 증가가 비교예 5, 6의 비교예 4에 대한 개선율 증가의 합보다 크고, 실시예 3의 비교예 7에 대한 개선율 증가가 비교예 8, 9의 비교예 7에 대한 개선율 증가의 합보다 큰 것으로 나타났다. 따라서, 소듐 디라우로일글루타민산리신 및 N-아세틸글루코사민의 두 가지 모두를 사용한 실시예 1, 2, 및 3의 제제는 각각 단독으로 사용할 경우의 비교예에 비해 주름 개선 효과에 있어서 상승적인 효과를 갖는 것으로 나타내었다. According to Table 6, the improvement rate of the wrinkles is greater than the sum of the improvement rate increase for Comparative Example 1 of Comparative Example 1 of Comparative Example 1 of Example 1, the improvement rate of Comparative Example 4 of Example 2 The increase is greater than the sum of the improvement rate for Comparative Example 4 of Comparative Examples 5 and 6, and the increase rate of improvement for Comparative Example 7 of Example 3 is greater than the sum of the improvement rate for Comparative Example 7 of Comparative Examples 8 and 9. appear. Therefore, the formulations of Examples 1, 2, and 3 using both sodium dilauroyl glutamic acid lysine and N-acetylglucosamine each have a synergistic effect on the wrinkle improvement effect as compared to the comparative example when used alone. It was shown to have.
또한, 상기 표 7에 따르면, 주름의 깊이에 있어서 실시예 1의 비교예 1에 대한 주름 깊이 감소율의 증가가 비교예 2, 3의 비교예 1에 대한 주름 깊이 감소율 증가의 합보다 크고, 실시예 2의 비교예 4에 대한 주름 깊이 감소율 증가가 비교예 5, 6의 비교예 4에 대한 주름 깊이 감소율 증가의 합보다 크고, 실시예 3의 비교예 7에 대한 주름 깊이 감소율 증가가 비교예 8, 9의 비교예 7에 대한 주름 깊이 감소율 증가의 합보다 큰 것으로 나타났다. 따라서, 소듐 디라우로일글루타민산리신 및 N-아세틸글루코사민의 두 가지 모두를 사용한 실시예 1, 2, 및 3의 제제는 각각 단독으로 사용할 경우의 비교예에 비해 주름 깊이 감소율에 있어서 상승적인 효과를 갖는 것으로 나타내었다. Further, according to Table 7, the increase in the wrinkle depth reduction rate for Comparative Example 1 of Example 1 in the depth of the wrinkles is greater than the sum of the increase in the wrinkle depth reduction rate for Comparative Example 1 of Comparative Examples 2 and 3, The increase in wrinkle depth reduction for Comparative Example 4 of 2 is greater than the sum of the increase in wrinkle depth reduction for Comparative Example 4 of Comparative Examples 5 and 6, and the increase in wrinkle depth reduction for Comparative Example 7 of Example 3 is greater than Comparative Example 8, It was found to be greater than the sum of the increase in the decrease in wrinkle depth for Comparative Example 7 of 9. Thus, the formulations of Examples 1, 2, and 3 using both sodium dilauroylglutamate lysine and N-acetylglucosamine each had a synergistic effect on the rate of wrinkle depth reduction compared to the comparative example when used alone. It was shown to have.
실험예 3: 피부 안전성 측정Experimental Example 3: Skin Safety Measurement
상기 실시예 1, 2, 3 및 비교예 2,3,5,6,8,9에서 제조한 화장료 조성물의 피부 첩포를 통한 피부안전성을 평가하기 위하여 다음과 같은 실험을 수행하였다. 화장품에 의한 피부 부작용을 경험한 적이 있었던 총 90 명(여성: 90 명)을 대상으 로 하여 환자의 등에 화장료 조성물을 포함하는 첩포를 도포한 후, 48 시간이 경가 후에 첩포를 제거한 다음, 1 시간 내지 2 시간 후에 일차 판정을 하였으며, 72 시간 및 96 시간 후에 판정하고, 그 결과를 하기 표 8에 나타내었다.In order to evaluate the skin safety through the skin patch of the cosmetic composition prepared in Examples 1, 2, 3 and Comparative Examples 2, 3, 5, 6, 8, 9, the following experiment was performed. A total of 90 women (90 women) who had experienced skin side effects by cosmetics were applied to the patient's back with a cosmetic composition containing the cosmetic composition, and after 48 hours, the patch was removed, and then 1 hour to Primary determinations were made after 2 hours, and after 72 and 96 hours, the results are shown in Table 8 below.
상기 표 8에 따르면, 본 발명에 따른 실시예 1, 2, 3 가 비교예 2,3,5,6,8,9에서 제조한 화장료 조성물보다 약간 안전하며, 실시예의 조성물 및 비교예 조성물은 모두 유의적으로 피부에 안전한 것으로 확인되었다. According to Table 8, Examples 1, 2, and 3 according to the present invention are slightly safer than the cosmetic compositions prepared in Comparative Examples 2, 3, 5, 6, 8, and 9, and both the compositions of the Examples and the Comparative Example compositions are Significantly safe for skin.
Claims (9)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080138733A KR101107312B1 (en) | 2008-12-31 | 2008-12-31 | Cosmetic composition for skin improvement and protection containing peptide |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080138733A KR101107312B1 (en) | 2008-12-31 | 2008-12-31 | Cosmetic composition for skin improvement and protection containing peptide |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20100080105A KR20100080105A (en) | 2010-07-08 |
KR101107312B1 true KR101107312B1 (en) | 2012-01-20 |
Family
ID=42641099
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020080138733A KR101107312B1 (en) | 2008-12-31 | 2008-12-31 | Cosmetic composition for skin improvement and protection containing peptide |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101107312B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230082390A (en) | 2021-12-01 | 2023-06-08 | 대봉엘에스 주식회사 | Method for prepation of pseudo-snake venom peptide in green solvents medium, and uses of the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010029674A (en) * | 1999-08-09 | 2001-04-06 | 마쓰모도 게이 이찌로 | Skin care agent, and health and beauty care food |
KR100615369B1 (en) | 2001-03-27 | 2006-08-25 | 카오카부시키가이샤 | External skin composition |
KR20100042254A (en) * | 2007-08-03 | 2010-04-23 | 가부시키가이샤 코세 | Liquid cosmetic preparation |
-
2008
- 2008-12-31 KR KR1020080138733A patent/KR101107312B1/en active IP Right Grant
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20010029674A (en) * | 1999-08-09 | 2001-04-06 | 마쓰모도 게이 이찌로 | Skin care agent, and health and beauty care food |
KR100615369B1 (en) | 2001-03-27 | 2006-08-25 | 카오카부시키가이샤 | External skin composition |
KR20100042254A (en) * | 2007-08-03 | 2010-04-23 | 가부시키가이샤 코세 | Liquid cosmetic preparation |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20230082390A (en) | 2021-12-01 | 2023-06-08 | 대봉엘에스 주식회사 | Method for prepation of pseudo-snake venom peptide in green solvents medium, and uses of the same |
KR20240155846A (en) | 2021-12-01 | 2024-10-29 | 대봉엘에스 주식회사 | Method for prepation of pseudo-snake venom peptide in green solvents medium, and uses of the same |
Also Published As
Publication number | Publication date |
---|---|
KR20100080105A (en) | 2010-07-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2659453T3 (en) | Topical compositions comprising Pichia anomala and chicory root extracts | |
JP6218380B2 (en) | External composition for improving skin quality | |
JP7309620B2 (en) | Use of an extract of pericarp of NEPHELIUM LAPPACEUM for hydrating skin and/or mucous membranes | |
JP2012041302A (en) | Skin cosmetic | |
KR20070081192A (en) | Cosmetic composition containing liposome containing oryzanol, rice bran oil and phospholipid as active ingredient | |
JP2018087148A (en) | γ-Oryzanol-containing cosmetics | |
KR20160131387A (en) | Composition for skin care | |
FR2969489A1 (en) | SACCHARIDIC POLYMER OBTAINED FROM MANIHOT ESCULENTA, PROCESS FOR OBTAINING AND USE AS A COSMETIC ACTIVE INGREDIENT SKIN TENSOR | |
CN113853195A (en) | Skin treatment composition and preservative system | |
JP2017193506A (en) | Skin cosmetics | |
WO2015147137A1 (en) | Ceramide-formulated external agent composition | |
JP5455292B2 (en) | Skin external composition | |
KR101107312B1 (en) | Cosmetic composition for skin improvement and protection containing peptide | |
KR101154772B1 (en) | Cosmetic composition containing the zizyphus jujuba fruit extract and walnut extract for moisturizing effect on the skin | |
JP2004075635A (en) | Moisturizing agent and external preparation for skin | |
US10406086B2 (en) | Moisturizer and cosmetic including the same | |
JP2009249366A (en) | Collagen production promotor and anti-aging skin preparation for external use | |
JP4500906B2 (en) | Cosmetic compounding agent and cosmetics containing the same | |
KR20050098583A (en) | Cosmetic composition containing polygonatum officinale powder for skin hydrating | |
US20240225986A9 (en) | Compositions and methods for improving the appearance of the skin | |
RU2836338C1 (en) | Cosmetic cream for dry skin care | |
RU2723483C1 (en) | Cosmetic hand cream | |
JP2004035431A (en) | Skin care preparation for externa use | |
KR20100033729A (en) | A cosmetic composition containing n-acetylglucosamine and vitamin c | |
JP2004244319A (en) | Cosmetic and external preparation for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20081231 |
|
PA0201 | Request for examination | ||
PG1501 | Laying open of application | ||
E902 | Notification of reason for refusal | ||
PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20110209 Patent event code: PE09021S01D |
|
E701 | Decision to grant or registration of patent right | ||
PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 20111010 |
|
GRNT | Written decision to grant | ||
PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 20120111 Patent event code: PR07011E01D |
|
PR1002 | Payment of registration fee |
Payment date: 20120112 End annual number: 3 Start annual number: 1 |
|
PG1601 | Publication of registration | ||
FPAY | Annual fee payment |
Payment date: 20150711 Year of fee payment: 4 |
|
PR1001 | Payment of annual fee |
Payment date: 20150711 Start annual number: 4 End annual number: 4 |
|
FPAY | Annual fee payment |
Payment date: 20160112 Year of fee payment: 5 |
|
PR1001 | Payment of annual fee |
Payment date: 20160112 Start annual number: 5 End annual number: 5 |
|
FPAY | Annual fee payment |
Payment date: 20170314 Year of fee payment: 6 |
|
PR1001 | Payment of annual fee |
Payment date: 20170314 Start annual number: 6 End annual number: 6 |
|
FPAY | Annual fee payment |
Payment date: 20180309 Year of fee payment: 7 |
|
PR1001 | Payment of annual fee |
Payment date: 20180309 Start annual number: 7 End annual number: 7 |
|
FPAY | Annual fee payment |
Payment date: 20190117 Year of fee payment: 8 |
|
PR1001 | Payment of annual fee |
Payment date: 20190117 Start annual number: 8 End annual number: 8 |
|
FPAY | Annual fee payment |
Payment date: 20200219 Year of fee payment: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20200219 Start annual number: 9 End annual number: 9 |
|
PR1001 | Payment of annual fee |
Payment date: 20210309 Start annual number: 10 End annual number: 10 |
|
PR1001 | Payment of annual fee |
Payment date: 20220111 Start annual number: 11 End annual number: 11 |
|
PR1001 | Payment of annual fee |
Payment date: 20221208 Start annual number: 12 End annual number: 12 |
|
PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20241022 |